Fuminori Hirano Selected Research

Fuminori Hirano Research Topics

5	Rheumatoid Arthritis 08/2022 - 06/2015
3	Infections 01/2017 - 06/2015
2	Liver Diseases (Liver Disease) 12/2006 - 02/2003
2	Hepatocellular Carcinoma (Hepatoma) 04/2003 - 07/2002
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 04/2003 - 02/2003
2	Disease Progression 04/2003 - 02/2003
2	Alcoholic Hepatitis 04/2003 - 02/2003
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2003 - 07/2002
1	Peptic Ulcer (Peptic Ulcers) 10/2020
1	Pneumonia (Pneumonitis) 01/2017
1	Pneumococcal Pneumonia 01/2017
1	Rheumatic Diseases (Rheumatism) 06/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2009
1	Hyperlipidemias (Hyperlipidemia) 02/2003
1	Chronic Hepatitis C 02/2003
1	Alcoholic Fatty Liver 02/2003

3	23-valent pneumococcal capsular polysaccharide vaccineIBA 01/2017 - 06/2015
3	Polysaccharides (Glycans)IBA 12/2015 - 06/2015
3	NF-kappa B (NF-kB)IBA 01/2009 - 02/2003
3	Chemokine CCL5IBA 04/2003 - 07/2002
2	Abatacept (Orencia)FDA Link 08/2022 - 12/2015
2	VaccinesIBA 01/2017 - 12/2015
2	Messenger RNA (mRNA)IBA 01/2009 - 07/2002
2	Bile Acids and Salts (Bile Acids)IBA 12/2006 - 07/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2003 - 02/2003
2	BezafibrateIBA 02/2003 - 07/2002
2	Fibric Acids (Fibrates)IBA 02/2003 - 07/2002
1	Biological ProductsIBA 08/2022
1	Antirheumatic Agents (DMARD)IBA 08/2022
1	Proton Pump InhibitorsIBA 10/2020
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 12/2015
1	golimumab FDA Link 12/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2015
1	Cyclin D1IBA 01/2009
1	ChemokinesIBA 04/2003
1	p38 Mitogen-Activated Protein KinasesIBA 04/2003
1	Triglycerides (Triacylglycerol)IBA 02/2003
1	Tamoxifen FDA LinkGeneric 02/2003
1	CytokinesIBA 02/2003
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 07/2002
1	Proteins (Proteins, Gene)FDA Link 07/2002
1	Chenodeoxycholic Acid (Chenix)FDA Link 07/2002
1	Fenofibrate (CiL)FDA LinkGeneric 07/2002

1	Endoscopic Hemostasis 10/2020